Addressing the Challenges in the Multidisciplinary Care of Patients with High-Risk NMSC

Release Date: November 14, 2025

Expiration Date: November 14, 2026

Jointly provided by Partners for Advancing Clinical Education and Medical Logix, LLC

This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

Estimated time to complete the activity is 6 hours.

Instructions for Credit

To successfully complete this activity and receive CE credit, please proceed with the activity until you have successfully answered all self-assessments, studied the educational content, and completed the evaluation. The evaluation will be made available immediately following.
 

In order to claim the maximum amount of credit available, you must complete all of the following:

• Baseline and Final Self-Assessments: 30 minutes each for a total of 1.0 credit
• Four self-study modules: 30-45 mintues each for a total of 2.5 credits 
• Two live sessions: 45 minutes each for a total of 1.5 credits
• Two Group Challenges: 30 minutes each for a total of 1.0 credits

Target Audience

This activity is intended for physicians, physician assistants/physician associates, pharmacists, nurse practitioners, and other healthecare providers who care for patients with non-melanoma skin cancers.

Educational Objectives                                                   

Upon completion of this activity, participants should be able to:

• Incorporate guideline recommendations to appropriately stratify high risk non-melanoma skin cancers.
• Appropriately use novel immunotherapies and/or refer patients with non-melanoma skin cancer to available clinical trials.
• Apply data on available immunotherapy options in immunosuppressed patients with non-melanoma skin cancers.
• Integrate guideline recommendations regarding the identification and management of irAEs in non-melanoma skin cancers into treatment regimens.
• Initiate multidisciplinary care pathways for appropriate high risk patients including  optimal use of multidisciplinary tumor boards.

Faculty

Travis Blalock, MD
Associate Professor
Emory Healthcare

Justine Cohen, DO
Senior Physician, Dana-Farber Cancer Center
Assistant Professor of Medicine
Harvard Medical School 

Emily Smith, MD
Associate Professor of Dermatology and Pathology
Saint Louis University/SSM Health

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Travis Blalock, MD, faculty for this educational activity, has the following relevant financial relationships:
Consultant, advisor, or speaker for Castle Biosciences, Evolve Medical Education, Horizon CME, MJH Life Sciences, Physician Eduation Resource, Regeneron Pharmaceauticals, and World Care Clinical

Justine Cohen, DO, faculty for this educational activity, has the following relevant financial relationships:
Consultant, advisor, or speaker for Bristol Myers Squibb and Replimune

Emily Smith, MD, faculty for this activity, has no relevant financial relationships.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Medical Logix, LLC.  Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this other/blended learning activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the posttest and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through Partner’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records. By sharing your Diplomate Board ID # and DOB, you are giving Partners permission to use this information/data to report your participation to these Boards JA-PARS.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 6.0
contact hours.

Pharmacy Continuing Education

Partners designates this continuing education activity for 6.0 contact hour(s) (0.6 EUs) of the
Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008073-9999-25-338-H01-P)
Type of Activity: Application

For Pharmacists: Upon successfully completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

For additional information about the accreditation of this activity, please visit https://partnersed.com.